New Delhi, May 28 -- Lincoln Pharmaceuticals, one of India's leading healthcare companies, announced a final dividend of Rs.1.80 per equity share for FY26 along with its March quarter and full-year FY26 financial results.

"The Board of Directors has recommended a dividend of 18% (i.e., Rs.1.80 per equity share) on equity shares having a face value of Rs.10 each for the financial year ended March 31, 2026, subject to the approval of shareholders at the ensuing Annual General Meeting (AGM) of the company," the company said in its earnings filing.

For Q4FY26, the company reported a consolidated net profit of Rs.11.63 crore, compared to Rs.11.57 crore in Q4FY25, registering a marginal growth of 0.52% year-on-year. Revenue from operations fo...